Ijzermans JNM - Search Results

1

First Report on Ex Vivo Delivery of Paracrine Active Human Mesenchymal Stromal Cells to Liver Grafts During Machine Perfusion.

Verstegen MMA, Mezzanotte L, Ridwan RY, Wang K, de Haan J, Schurink IJ, Sierra Parraga JM, Hoogduijn M, Kessler BM, Huang H, Hall SRR, Ijzermans JNM, Löwik CWGM, van der Laan LJW, de Jonge J. Verstegen MMA, et al. Among authors: ijzermans jnm. Transplantation. 2020 Jan;104(1):e5-e7. doi: 10.1097/TP.0000000000002986. Transplantation. 2020. PMID: 31609902 Free article. No abstract available.

2

Importance of portal flow diversion in experimental auxiliary partial orthotopic liver transplantation.

de Jonge J, Zondervan PE, IJzermans JN, Metselaar HJ, Tilanus HW. de Jonge J, et al. Transplantation. 2000 Jul 15;70(1):44-7. Transplantation. 2000. PMID: 10919573

3

Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP).

de Jonge J, Groenland TH, Metselaar HJ, IJzermans JN, van Vliet HH, Visser L, Tilanus HW. de Jonge J, et al. Anesth Analg. 2002 May;94(5):1127-31, table of contents. doi: 10.1097/00000539-200205000-00012. Anesth Analg. 2002. PMID: 11973173 Free article.

4

Portal flow diversion is essential for graft survival in canine auxiliary partial orthotopic liver transplantation.

de Jonge J, Zondervan PE, Kooi PP, IJzermans JN, Metselaar HJ, Tilanus HW. de Jonge J, et al. Eur Surg Res. 2003 Jan-Feb;35(1):14-21. doi: 10.1159/000067030. Eur Surg Res. 2003. PMID: 12566782

5

Liver transplantation, solvent-detergent treated plasma and antifibrinolytics.

de Jonge J, Groenland TH, Metselaar HJ, IJzermans JN, van Vliet HH, Visser L, Tilanus HW. de Jonge J, et al. Anesth Analg. 2003 Apr;96(4):1231-1232. doi: 10.1213/01.ANE.0000044045.61979.3D. Anesth Analg. 2003. PMID: 12651692 No abstract available.

6

No association between tumor necrosis factor-alpha production and gene polymorphisms among inbred rat strains.

Warlé MC, van der Laan LJ, Kusters JG, Pot RG, Hop WC, Segeren KC, Ijzermans JN, Metselaar HJ, Tilanus HW. Warlé MC, et al. Transpl Immunol. 2005 Jun;14(2):77-82. doi: 10.1016/j.trim.2005.04.002. Transpl Immunol. 2005. PMID: 15935297

7

Allosuppressive donor CD4+CD25+ regulatory T cells detach from the graft and circulate in recipients after liver transplantation.

Demirkiran A, Bosma BM, Kok A, Baan CC, Metselaar HJ, Ijzermans JN, Tilanus HW, Kwekkeboom J, van der Laan LJ. Demirkiran A, et al. J Immunol. 2007 May 15;178(10):6066-72. doi: 10.4049/jimmunol.178.10.6066. J Immunol. 2007. PMID: 17475831

8

Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities.

Hoogduijn MJ, Crop MJ, Peeters AM, Van Osch GJ, Balk AH, Ijzermans JN, Weimar W, Baan CC. Hoogduijn MJ, et al. Stem Cells Dev. 2007 Aug;16(4):597-604. doi: 10.1089/scd.2006.0110. Stem Cells Dev. 2007. PMID: 17784833

9

Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation.

Sewgobind VD, van der Laan LJ, Klepper M, Ijzermans JN, Tilanus HW, Weimar W, Baan CC. Sewgobind VD, et al. Clin Transplant. 2008 Sep-Oct;22(5):579-86. doi: 10.1111/j.1399-0012.2008.00827.x. Epub 2008 Apr 23. Clin Transplant. 2008. PMID: 18435785

10

The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.

Sewgobind VD, Kho MM, van der Laan LJ, Hendrikx TK, van Dam T, Tilanus HW, IJzermans JN, Weimar W, Baan CC. Sewgobind VD, et al. Nephrol Dial Transplant. 2009 May;24(5):1635-44. doi: 10.1093/ndt/gfn778. Epub 2009 Jan 28. Nephrol Dial Transplant. 2009. PMID: 19176684 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

718 results

Search Page

Filters